Clinical Trials Directory

Trials / Unknown

UnknownNCT05172713

Outcomes of Patients Who Had an Incomplete Colonoscopy After a Positive Fecal Immunological Test

Outcomes of Patients Who Had an Incomplete Colonoscopy After a Positive Fecal Immunological Test: Study of Practices in the Grand-Est

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
50 Years – 75 Years
Healthy volunteers
Not accepted

Summary

In France, colorectal cancer (CRC) is the second leading cause of cancer death. Its organized screening (Organized ColoRectal Cancer Screening: DOCCR), now carried out by immunological test for occult blood in the stool, has proven its effectiveness. When the immunological test is positive, the Haute Autorité de Santé recommends a total colonoscopy. In 5 to 10% of cases, this colonoscopy is incomplete. The renewal of the endoscopic procedure or the performance of additional second-line examinations are then recommended. At present, however, the respective place of second-line examinations to be performed in this situation is not the subject of specific and validated recommendations.

Conditions

Timeline

Start date
2021-01-16
Primary completion
2022-04-01
Completion
2022-04-16
First posted
2021-12-29
Last updated
2021-12-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05172713. Inclusion in this directory is not an endorsement.

Outcomes of Patients Who Had an Incomplete Colonoscopy After a Positive Fecal Immunological Test (NCT05172713) · Clinical Trials Directory